Internal Medicine

Susan K. Schultz, MD

Portrait

Co-Director
Co-Director
Director
Vice-Chair for Clinical Translation
Professor of Psychiatry
Professor of Internal Medicine

Contact Information

Office: 2-207 Medical Education Building
Iowa City, IA 52242
Office Phone: 319-335-6956

Email: susan-schultz@uiowa.edu
Web: UIHC Profile Page

Education

BA, Biology, English, Nebraska Wesleyan University, Lincoln, NE
MD, University of Nebraska Medical Center, College of Medicine, Omaha, NE

Residency, Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, IA
Post Doctoral, Clinical Neurobiology - Schizophrenia Research, University of Iowa, Iowa City, IA

Licensure and Certifications

Medical License Iowa Board of Medicine
National Board of Medical Examiners
ABPN Subspecialty Certification: Psychosomatic Medicine American Board of Psychiatry and Neurology
ABPN Subspecialty Certification: Geriatric Psychiatry American Board of Psychiatry and Neurology
ABPN Certification: Psychiatry American Board of Psychiatry and Neurology

All Publications

Tsuang M, Van Os J, Tandon R, Barch D, Bustillo J, Gaebel W, Gur R, Heckers S, Malaspina D, Owen M, Schultz S, Carpenter W.  Attenuated Psychosis Syndrome in DSM-5.  Schizophr Res.  2014 October 1. 150(1):31-35.
[Link]

Zhang Y, Xu Z, Shen X, Pan W, Alzheimer's Disease Neuroimaging Initiative .  Testing for association with multiple traits in generalized estimation equations, with application to neuroimaging data.  Neuroimage.  2014 August 1. 96:30925.
[PubMed]

Perez-Palma E, Bustos B, Villaman C, Alarcon M, Avila M, Ugarte G, Reyes A, Opazo C, De Ferrari G.  Alzheimer's Disease Neuroimaging Initiative; NIA-LOAD/NCRAD Family Study Group. Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.  PLoS One.  2014 April 22. 9(4):e95413.
[PubMed]

Ortiz A, Gorriz J, Ramirez J, Martinez-Murcia F, Alzheimer's Disease Neuroimaging Initiative .  Automatic ROI selection in structural brain MRI using SOM 3D projection.  PLoS One.  2014 April 11. 9(4):e93851.
[PubMed]

Arndt S, Schultz S.  Epidemiology and Demography of Alcohol and the Older Person in Substance Use and Older People.  2014. 

Mattsson N, Insel P, Tosun D, Zhang J, Jack Jr. C, Galasko D, Weiner M, Alzheimer's Disease Neuroimaging Initiative .  Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.  PLoS One.  2013 December 31. 8(12):e85443.

Iglesias J, Sabuncu M, Van Leemput K, Alzheimer’s Disease Neuroimaging Initiative .  Improved inference in Bayesian segmentation using Monte Carlo sampling: application to hippocampal subfield volumetry.  Med Image Anal.  2013 October 17. 17(7):766-778.

Tandon R, Heckers S, Bustillo J, Barch D, Gaebel W, Gur R, Malaspina D, Owen M, Schultz S, Tsuang M, Van Os J, Carpenter W.  Catatonia in DSM-5.  Schizophr Res.  2013 October. 150(1):26-30.
[PubMed]

Tandon R, Gaebel W, Barch D, Bustillo J, Gur R, Heckers S, Malaspina D, Owen M, Schultz S, Tsuang M, Van Os J, Carpenter W.  Definition and description of schizophrenia in the DSM-5 .  Schizophrenic Research.  2013 October. 150(1):3-10.
[Link]

Barch D, Bustillo J, Gaebel W, Gur R, Heckers S, Malaspina D, Owen M, Schultz S, Tandon R, Tsuang M, Van Os J, Carpenter W.  Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5.  Schizophrenia Research.  2013 October. 150(1):15-20.
[Link]

Malaspina D, Owen M, Heckers S, Tandon R, Bustillo J, Schultz S, Barch D, Gaebel W, Gur R, Tsuang M, Van Os J, Carpenter W.  Schizoaffective Disorder in the DSM-5.  Schizophr Res.  2013 October. 150(1):21-25.
[Link]

Bryant C, Giovanello K, Ibrahim J, Chang J, Shen D, Peterson B, Zhu H, Alzheimer's Disease Neuroimaging Initiative .  Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study.  PLoS One.  2013 August 28. 8(8):E71723.

Bradshaw E, Chibnik L, Keenan B, Ottoboni L, Raj T, Tang A, Rosenkrantz L, Imboywa S, Lee M, Von Korff A, Alzheimer Disease Neuroimaging Initiative , Morris M, Evans D, Johnson K, Sperling R, Schneider J, Bennett D, De Jager P,  ,  ,  .  CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology.  Nat Neurosci.  2013 July. 16(7):848-850.

Martinez-Muncia F, Gorriz J, Ramirez J, Puntonet C, Illan I, Alzheimer's Disease Neuroimaging Initiative .  Functional activity maps based on significance measures and Independent Component Analysis.  Comput Methods Programs Biomed.  2013 July. 111(1):255-268.
[PubMed]

Schultz S.  Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.  2013  June.

Heckers S, Barch D, Bustillo J, Gaebel W, Gur R, Malaspina D, Owen M, Schultz S, Tandon R, Tsuang M, Van Os J, Carpenter W.  Structure of the psychotic disorders classification in DSM-5.  Schizophr Res.  2013 May 23. 150(1):11-14.
[PubMed]

Fjell A, McEvoy L, Holland D, Dale A, Walhovd K, Alzheimer's Disease Neuroimaging Initiative .  Brain changes in older adults at very low risk for Alzheimer's disease.  J Neurosci. .  2013 May 8. 33(19):8237-8242.
[PubMed]

Smith M, Schultz S, Seydel L, Reist J, Kelly M, Weckman M, Gryzlak B, Carnahan R.  Improving antipsychotic agent use in nursing homes: development of an algorithm for treating problem behaviors in dementia.  Journal of Gerontology Nursing.  2013 May. 39(5):24-35.
[PubMed]

Dai Y, Wang Y, Wu G, Shi F, Shen D, Alzheimer's Disease Neuroimaging Initiative ,  .  aBEAT: a toolbox for consistent analysis of longitudinal adult brain MRI.  PLoS One.  2013. 8(4):e60344.

Nguyen C, Yamada T, Beglinger L, Cavanaugh J, Denburg N, Schultz S.  Cognitive features ten or more years after successful breast cancer survival: Comparisons across types of cancer interventions.  Psycho-oncology.  2013. 22(4):862-8.
[PubMed]

Freedman R, Lewis D, Michels R, Pine D, Schultz S, Tamminga C, Gabbard G, Gau S, Javitt D, Oquendo M, Shrout P, Vieta E, Yager J.  The initial field trials of DSM-5: new blooms and old thorns..  The American Journal of Psychiatry.  2013. 170(1):1-5.
[PubMed]

Schultz S.  Late-life depression research: lessons learned from the metabolic syndrome.  Am J Psychiatry..  2012 November. 169(11):1133-1136.
[PubMed]

Carnahan R, Abrams M, Weckmann M, Savage B, Daly J, Kelly M, Levy B, Mulhausen P, Reist J, Seydel L, Smith M, Raether R, Abrams E, Holland R, Schultz S.  Development of a reader-friendly patient and family guide to facilitate shared decision making on antipsychotic use in dementia.  Presented at Health Literacy Iowa and New Readers of Iowa Conference.  2012 April. 

Freedman R, Lewis D, Michels R, Pine D, Schultz S, Tamminga C, Seawell M.  2012 in review.  The American Journal of Psychiatry.  2012. 169(12):1233-7.
[PubMed]

Moser D, Boles Ponto L, Miller I, Schultz S, Menda Y, Arndt S, Nopoulos P.  Cerebral blood flow and neuropsychological functioning in elderly vascular disease patients.  Journal of Clinical and Experimental Neuropsychology.  2012. 34(2):220-5.
[PubMed]

Carnahan R, Gryzlak B, Weckmann M, Kelly M, Reist J, Smith M, Lenoch S, Daly J, Levy B, Seydel L, Schultz S.  Decisional aides to train non-psychiatrists in evidence based use of antipsychotics in dementia.  Poster presented at the College of Psychiatric and Neurologic Pharmacists Annual Meeting.  2012. 

Devanand D, Mintzer J, Schultz S, Andrews H, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming C, Pelton G, Levin B.  Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease.  The New England Journal of Medicine.  2012. 367:1497-507.

Devanand D, Mintzer J, Schultz S, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming C, Pelton G, Andrews H, Levin B.  The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.  The American Journal of Geriatric Psychiatry.  2012. 20(4):362-73.
[PubMed]

Duff K, Lyketsos C, Beglinger L, Chelune G, Moser D, Arndt S, Schultz S, Paulsen J, Petersen R, McCaffrey R,  .  Practice effects predict cognitive outcome in amnestic Mild Cognitive Impairment.  Am J Geriatr Psychiatry.  2011 November. 19(11):932-939.
[Link]

Devanand D, Mintzer J, Schultz S, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming C, Pelton G, Andrews H, Levin B.  The Antipsychotic Discontinuation in Alzheimer's Disease (ADAD) trial: clinical rationale and study design.  Presented at the International Congress on Alzheimer's Disease.  2011 July. 

Ravven S, Zimmerman M, Schultz S, Wallace R.  12-month herbal medicine use for mental health from the national Comorbidity Survey Replication (NCS-R).  Annals of Clinical Psychiatry.  2011. 23(2):83-94.
[PubMed]

Freedman R, Lewis D, Michels R, Pine D, Schultz S, Tamminga C.  2011 in review.  The American Journal of Psychiatry.  2011. 168(12):1241-4.
[PubMed]

Onwuameze O, Schultz S, Paradiso S.  An initial study of modifiable and non-modifiable factors for late-life psychosis.  International Journal of Psychiatry in Medicine.  2011. 42(4):437-51.
[PubMed]

Filips J, Bayless J, Moser D, Crossett J, Schultz S.  Associations between cognitive impairment and depressive symptoms in late-life: gender effects.  Presented at First Annual International Congress for Geriatric Psychoneuropharmacology.  2011. 

Devanand D, Schultz S.  Consequences of antipsychotic medications for the dementia patient.  The American Journal of Psychiatry.  2011. 168(8):767-9.
[PubMed]

Weckmann M, Daly J, Gryzlak B, Kelly M, Lenoch S, Levy B, Reist J, Schultz S, Seydel L, Smith M, Carnahan R.  Decisional aides to train non-psychiatrists in evidence based use of antipsychotics in dementia.  Presented at The Academy of Psychosomatic Medicine Annual Meeting.  2011. 

Faison W, Schultz S.  Part V: Diagnostic Issues Relating to Lifespan from Adulthood into Later Life In: The Conceptual Evolution of DSM-5.  American Psychiatric Publishing.  2011. 

Hamsakutty H, Yamada T, Denburg N, Magnotta V, Beglinger L, Nopoulos P, Schultz S.  Structural MRI Correlates of Neurocognitive Performance in Breast Cancer Survivors.  American Association for Geriatric Psychiatry.  2011. 

Schultz S.  The hazardous territory of late-life depression: a challenge to geropsychiatry.  The American Journal of Geriatric Psychiatry.  2011. 19(3):197-200.
[PubMed]

Arndt S, Clayton R, Schultz S.  Trends in substance abuse treatment 1998-2008: increasing older adult first-time admissions for illicit drugs.  The American Journal of Geriatric Psychiatry.  2011. 19(8):704-11.
[PubMed]

Duff K, Beglinger L, Moser D, Paulsen J, Schultz S, Arndt S.  Predicting Cognitive Change in Older Adults: The Relative Contribution of Practice Effects.  Arch Clin Neuropsychol.  2010 March. 25(2):81-88.
[Link]

Kang H, Smith M, Buckwalter K, Ellingrod V, Schultz S.  Anxiety, depression, and cognitive impairment in dementia-specific and traditional assisted living.  Journal of Gerontological Nursing.  2010. 36(1):18-30; quiz 32-3.
[PubMed]

Kaldjian L, Shinkunas L, Bern-Klug M, Schultz S.  Dementia, goals of care, and personhood: a study of surrogate decision makers' beliefs and values.  The American Journal of Hospice & Palliative Care.  2010. 27(6):387-97.
[PubMed]

Yamada T, Denburg N, Beglinger L, Schultz S.  Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy.  The Journal of Neuropsychiatry and Clinical Neurosciences.  2010. 22(1):48-54.
[PubMed]

Duff K, Beglinger L, Moser D, Schultz S, Paulsen J.  Practice effects and outcome of cognitive training: preliminary evidence from a memory training course.  The American Journal of Geriatric Psychiatry.  2010. 18(1):91.
[PubMed]

Koh S, Blank K, Cohen C, Cohen G, Faison W, Kennedy G, Kyomen H, Liptzin B, Meador K, Rohrbaugh R, Rusch B, Sakauye K, Schultz S, Streim J.  Public's view of mental health services for the elderly: responses to Dear Abby.  Psychiatric Services ,Washington, D.C.  2010. 61(11):1146-9.
[PubMed]

Tamminga C, Michels R, Pine D, Schultz S, Lewis D, Freedman R.  2009 in review.  The American Journal of Psychiatry.  2009. 166(12):1318-21.
[PubMed]

Schultz S, Menda Y, Denburg N, Ponto L.  [18F]Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Study of Brain Metabolism among Elderly Women Breast Cancer Survivors.  Presented at the American College of Neuropsychopharmacology.  2009. 

Turvey C, Schultz S, Beglinger L, Klein D.  A longitudinal community-based study of chronic illness, cognitive and physical function, and depression.  The American Journal of Geriatric Psychiatry.  2009. 17(8):632-41.
[PubMed]

Sakauye K, Streim J, Kennedy G, Kirwin P, Llorente M, Schultz S, Srinivasan S.  AAGP position statement: disaster preparedness for older Americans: critical issues for the preservation of mental health.  The American Journal of Geriatric Psychiatry.  2009. 17(11):916-24.
[PubMed]

Freedman R, Lewis D, Michels R, Pine D, Schultz S, Tamminga C, Andreasen N, Brady K, Brent D, Brzustowicz L, Carter C, Eisenberg L, Goldman H, Javitt D, Leibenluft E, Lieberman J, Milrod B, Oquendo M, Rosenbaum J, Rush A, Siever L, Suppes P, Weissman M, Roy M, Scully J, Yager J.  Conflict of interest-- an issue for every psychiatrist.  The American Journal of Psychiatry.  2009. 166(3):274.
[PubMed]

Kaldjian L, Shinkunas L, Bern-Klug M, Schultz S.  Dementia, goals of care, and surrogate decision making toward the end of life.  Presented at The Society of General Internal Medicine 32nd Annual Meeting.  2009. 

Yamada T, Denburg N, Beglinger L, Schultz S.  Neuropsychological Outcomes of Long-term Breast Cancer Survivors.  Presented at The American Association for Geriatric Psychiatry.  2009. 

Schultz S.  Atypical antipsychotic medications in Alzheimer's disease: effectiveness versus expectations.  The American Journal of Psychiatry.  2008. 165(7):787-9.
[PubMed]

Smith M, Buckwalter K, Kang H, Ellingrod V, Schultz S.  Dementia care in assisted living: needs and challenges.  Issues in Mental Health Nursing.  2008. 29(8):817-38.
[PubMed]

Smith M, Buckwalter K, Kang H, Ellingrod V, Schultz S.  Dementia-specific assisted living: clinical factors and psychotropic medication use.  Journal of the American Psychiatric Nurses Association.  2008. 14(1):39-49.
[PubMed]

Salzman C, Jeste D, Meyer R, Cohen-Mansfield J, Cummings J, Grossberg G, Jarvik L, Kraemer H, Lebowitz B, Maslow K, Pollock B, Raskind M, Schultz S, Wang P, Zito J, Zubenko G.  Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.  The Journal of Clinical Psychiatry.  2008. 69(6):889-98.
[PubMed]

Schultz S, Magnotta V, Duff K, Boles Ponto L, Moser D.  Evaluation of older persons with mild cognitive deficits: potential utility of magnetic resonance imaging.  Annals of Clinical Psychiatry.  2008. 20(4):204-8.
[PubMed]

Schultz S.  Moving forward in clinical trials for late-life disorders.  The American Journal of Geriatric Psychiatry.  2008. 16:1-4.

Duff K, Beglinger L, Van Der Heiden S, Moser D, Arndt S, Schultz S, Paulsen J.  Short-term practice effects in amnestic mild cognitive impairment: implications for diagnosis and treatment.  International Psychogeriatrics.  2008. 20(5):986-99.
[PubMed]

Smith M, Buckwalter K, Kang H, Schultz S, Ellingrod V.  Tales from the field: what the nursing research textbooks will not tell you.  Applied Nursing Research.  2008. 21(4):232-6.
[PubMed]

Schultz S.  Depression in the older adult: The challenge of medical comorbidity.  The American Journal of Psychiatry.  2007. 164(6):847-8.
[PubMed]

O'Leary D, Block R, Koeppel J, Schultz S, Magnotta V, Ponto L, Watkins G, Hichwa R.  Effects of smoking marijuana on focal attention and brain blood flow.  Human Psychopharmacology.  2007. 22(3):135-48.
[PubMed]

Fiedorowicz J, Moser D, Hynes S, Belinger L, Schultz S, Ellingrod V.  LA allelic heterozygosity of the 5HTTLPR polymorphism is associated with higher cognitive function and lower interpersonal sensitivity.  Psychiatric Genetics.  2007. 17(1):3-4.

Sattar S, Schultz S, Arndt S, Soundy T, Petty F.  Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.  South Dakota Medicine.  2007. 60(11):437, 439-41, 443.
[PubMed]

Schultz S, Alexopoulos G.  Part III: The Elderly. Aging-related diagnostic variations: Age and Gender Considerations in Psychiatric Diagnosis: A Research Agenda for DSM-V.  American Psychiatric Publishing.  2007. 

Faison W, Schultz S, Aerssens J, Alvidrez J, Anand R, Farrer L, Jarvik L, Manly J, McRae T, Murphy G, Olin J, Regier D, Sano M, Mintzer J.  Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: Challenges for the future.  International Psychogeriatrics.  2007. 19(3):539-58.
[PubMed]

Duff K, Beglinger L, Schultz S, Moser D, McCaffrey R, Haase R, Westervelt H, Langbehn D, Paulsen J.  Practice effects in the prediction of long-term cognitive outcome in three patient samples: A novel prognostic index.  Archives of Clinical Neuropsychology.  2007. 22(1):15-24.
[PubMed]

Turvey C, Schultz S, Klein D.  Alcohol use and health outcomes in the oldest old.  Substance Abuse Treatment, Prevention, and Policy.  2006. 1:8.
[PubMed]

Forman-Hoffman V, Ruffin T, Schultz S.  Basal metabolic rate in anorexia nervosa patients: using appropriate predictive equations during the refeeding process.  Annals of Clinical Psychiatry .  2006. 18(2):123-7.
[PubMed]

Lewis D, Michels R, Pine D, Schultz S, Tamminga C, Freedman R.  Conflict of interest.  The American Journal of Psychiatry.  2006. 163(4):571-3.
[PubMed]

Freedman R, Lewis D, Michels R, Pine D, Schultz S, Tamminga C, Patterson S, McIntyre J, Goldman H, Yudofsky S, Hales R, Rapaport M, Hales D, Krajeski J, Kupfer D, Badaracco M, Scully J.  Conflict of interest, round 2.  The American Journal of Psychiatry.  2006. 163(9):1481-3.
[PubMed]

Chen X, Magnotta V, Duff K, Boles Ponto L, Schultz S.  Donepezil effects on cerebral blood flow in older adults with mild cognitive deficits.  The Journal of Neuropsychiatry and Clinical Neurosciences.  2006. 18(2):178-85.
[PubMed]

Geriatric Review Syllabus, 6th edition.  American Geriatrics Society and Kendall Hunt;  2006.

Boles Ponto L, Magnotta V, Moser D, Duff K, Schultz S.  Global cerebral blood flow in relation to cognitive performance and reserve in subjects with mild memory deficits.  Molecular Imaging and Biology.  2006. 8(6):363-72.
[PubMed]

Bishop J, Moline J, Ellingrod V, Schultz S, Clayton A.  Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects.  Neuropsychopharmacology.  2006. 31(10):2281-8.
[PubMed]

Abrams T, Barnett M, Hoth A, Schultz S, Kaboli P.  The relationship between hearing impairment and depression in older veterans.  Journal of the American Geriatrics Society.  2006. 54(9):1475-7.
[PubMed]

Moser D, Reese R, Hey C, Schultz S, Arndt S, Beglinger L, Duff K, Andreasen N.  Using a brief intervention to improve decisional capacity in schizophrenia research.  Schizophrenia Bulletin.  2006. 32(1):116-20.
[PubMed]

Schultz S.  Info-connect brochure: Treating depression in Dementia.  Educational module produced by the Geriatric Education Center.  2005. 

Moser D, Reese R, Schultz S, Benjamin M, Arndt S, Fleming F, Andreasen N.  Informed consent in medication-free schizophrenia research.  The American Journal of Psychiatry.  2005. 162(6):1209-11.
[PubMed]

Alexopoulos G, Schultz S, Lebowitz B.  Late-life depression: A model for medical classification.  Biological Psychiatry.  2005. 58(4):283-9.
[PubMed]

Schultz S, Ellingrod V.  Late-Life Schizophrenia: Optimizing Treatment.  Current Psychosis and Therapeutics Reports.  2005. 3(1):5-8.

Smith M, Schultz S.  Managing perplexing patients: The case of Helen.  Issues in Mental Health Nursing.  2005. 26(1):47-63.
[PubMed]

Sakauye K, Liptzin B, Blank K, Cohen C, Schultz S.  Medicare Managed Mental Health Care: A Looming Crisis.  Psychiatric Services.  2005. 
[PubMed]

Schultz S, Moser D, Bishop J, Ellingrod V.  Phobic anxiety in late-life in relationship to cognition and 5HTTLPR polymorphism.  Psychiatric Genetics.  2005. 15(4):305-6.
[PubMed]

Schultz S.  The neuropsychiatry of aging.  The American Journal of Psychiatry.  2005. 162(11):1993-5.
[PubMed]

Schultz S, Hoth A, Buckwalter K.  Anxiety and impaired social function in the elderly.  Annals of Clinical Psychiatry.  2004. 16:1-4.
[PubMed]

Moser D, Hoth K, Robinson R, Paulsen J, Sinkey C, Benjamin M, Schultz S, Haynes W.  Blood vessel function and cognition in elderly patients with atherosclerosis.  Stroke.  2004. 35(11):e369-72.
[PubMed]

Burke W, Schultz S, Smith M.  Management of Anxiety in Late life.  Annals of Long-term Care.  2004. 12(8):25-33.

Duff K, Ponto L, Moser D, Schultz S.  Mild Cognitive Impairment assessed by [15O] water Positron Emission Tomography: Differences in Cerebral Blood Flow among Cognitive Subtypes.  American College of Neuropsychopharmacology.  2004. 

Boles Ponto L, Schultz S, Leonard Watkins G, Hichwa R.  Technical issues in the determination of cerebrovascular reserve in elderly subjects using 15O-water PET imaging.  NeuroImage.  2004. 21(1):201-10.
[PubMed]

Schultz S.  Memory Problems.  American Geriatrics Society's Foundation for Health in Aging;  2003.  Available from: http://www.healthinaging.org/public_education/eldercare/17.xml

Schultz S.  Biological changes with aging and schizophrenia.  American Psychiatric Press.  2003. 

Schultz S, Ponto L, Magnotta V, Moser D, Magnotta V, Watkins G, Hichwa R.  Cerebrovascular reserve capacity in mild cognitive impairment assessed by [15O] water positron emission tomography.  American College of Neuropsychopharmacology.  2003. 

Anderson R, Schultz S, Buckwalter K, Schneider J.  Clinical characteristics of older adults admitted to an inpatient psychiatric unit: implications for resource allocation.  Journal of Mental Health & Aging.  2003. 9(4):211-221.

Ponto L, Schultz S.  Ginkgo biloba extract: review of CNS effects..  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.  2003. 15(2):109-19.
[PubMed]

Schultz S, Arndt S, Liesveld J.  Locations of facilities with special programs for older substance abuse clients in the US..  International journal of geriatric psychiatry.  2003. 18(9):839-43.
[PubMed]

Schultz S, Ellingrod V, Turvey C, Moser D, Arndt S.  The influence of cognitive impairment and behavioral dysregulation on daily functioning in the nursing home setting.  The American Journal of Psychiatry.  2003. 160(3):582-4.
[PubMed]

Ellingrod V, Schultz S, Arndt S.  Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6.  Pharmacotherapy.  2002. 22(11):1416-9.
[PubMed]

Schultz S, O'Leary D, Boles Ponto L, Arndt S, Magnotta V, Watkins G, Hichwa R, Andreasen N.  Age and regional cerebral blood flow in schizophrenia: age effects in anterior cingulate, frontal, and parietal cortex.  The Journal of Neuropsychiatry and Clinical Neurosciences.  2002. 14(1):19-24.
[PubMed]

Schultz S, Arndt S, Lutz G, Petersen A, Turvey C.  Alcohol use among older persons in a rural state.  The American Journal of Geriatric Psychiatry.  2002. 10(6):750-3.
[PubMed]

Schultz S, Ponto L, Magnotta V, Moser D, Magnotta V, Watkins G, Hichwa R.  Assessment of cerebrovascular reserve capacity among persons with mild cognitive impairment using [15O] water positron emission tomography.  American College of Neuropsychopharmacology.  2002. 

Kraemer H, Schultz S, Arndt S.  Biomarkers in psychiatry: Methodological issues.  The American Journal of Geriatric Psychiatry.  2002. 10(6):653-9.
[PubMed]

Moser D, Schultz S, Arndt S, Benjamin M, Fleming F, Brems C, Paulsen J, Appelbaum P, Andreasen N.  Capacity to provide informed consent for participation in schizophrenia and HIV research.  The American Journal of Psychiatry.  2002. 159(7):1201-7.
[PubMed]

Ellingrod V, Schultz S, Ekstam-Smith K, Kutscher E, Turvey C, Arndt S.  Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.  Pharmacotherapy.  2002. 22(1):1-5.
[PubMed]

Ellingrod V, Miller D, Schultz S, Wehring H, Arndt S.  CYP2D6 polymorphisms and atypical antipsychotic weight gain.  Psychiatric Genetics.  2002. 12(1):55-8.
[PubMed]

O'Leary D, Block R, Koeppel J, Flaum M, Schultz S, Andreasen N, Ponto L, Watkins G, Hurtig R, Hichwa R.  Effects of smoking marijuana on brain perfusion and cognition.  Neuropsychopharmacology.  2002. 26(6):802-16.
[PubMed]

Schultz S.  On reaching visible (poem).  Sage Publications; London.  2002. 

Fuller R, Schultz S, Andreasen N.  Positive and negative symptoms in schizophrenia.  Blackwell Publishing.  2002. 

Arndt S, Schultz S, Turvey C, Petersen A.  Screening for alcoholism in the primary care setting: Are we talking to the right people?.  The Journal of Family Practice.  2002. 51(1):41-6.
[PubMed]

Schultz S, Ellingrod V, Moser D, Kutschner E, Turvey C, Arndt S.  The influence of cognitive impairment and psychiatric symptoms on daily functioning in nursing facilities: a longitudinal study.  Annals of Clinical Psychiatry .  2002. 14(4):209-13.
[PubMed]

Schultz S, Ellingrod V, Ekstam-Smith K.  Psychiatric syndromes in the nursing home patient: longitudinal follow-up study.  Presented at the American College of Neuropsychopharmacology Annual Meeting.  2001 December 12. 

Turvey C, Schultz S, Arndt S, Ellingrod V, Wallace R, Herzog R.  Caregiver report of hallucinations and paranoid delusions in elders aged 70 or older.  International Psychogeriatrics.  2001. 13(2):241-9.
[PubMed]

Schultz S, Ellingrod V, Moser D.  Clinical characteristics of late-life psychosis: A comparison of diagnostic groups.  American Journal of Geriatric Psychiatry.  2001. 9(3):S1:90.

Schultz S.  Conclusions: Late-life schizophrenia.  Harvard Review of Psychiatry.  2001. 9(2):84-7.
[PubMed]

Schultz S, Ellingrod V, Fleming F, Andreasen N.  The association between risk factors for tardive dyskinesia and phenylalanine-induced abnormal movements in schizophrenia.  Human Psychopharmacology.  2001. 16(3):273-277.
[PubMed]

Cem Atbasoqlu E, Schultz S, Andreason N,  .  The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia.  J Neuropsychiatry Clin Neurosci.  2001. 13(3):336-341.
[PubMed]

Moser D, Ferneyhough K, Bauer R, Arndt S, Schultz S, Haynes W, Staples E, Alexander J, Davies L, O'Brien D.  Unilateral vs. bilateral ultrasound in the monitoring of cerebral microemboli.  Ultrasound in Medicine & Biology.  2001. 27(6):757-60.
[PubMed]

Schultz S.  Dementia Teaching Module in the Iowa Geriatric Education Center (IGEC) web-based learning program for University of Iowa medical students.  2000. 

O'Leary D, Block R, Flaum M, Schultz S, Boles Ponto L, Watkins G, Hurtig R, Andreasen N, Hichwa R.  Acute marijuana effects on rCBF and cognition: a PET study.  Neuroreport.  2000. 11(17):3835-41.
[PubMed]

Schultz S, Ho B, Andreasen N.  Age and gender effects on the expression of depressive symptoms in schizophrenia.  American College of Neuropsychopharmacology.  2000. 

Ellingrod V, Schultz S, Arndt S.  Association between cytochrome P4502D6 (CYP2D6) genotype, antipsychotic exposure, and abnormal involuntary movement scale (AIMS) score.  Psychiatric Genetics.  2000. 10(1):9-11.
[PubMed]

Schultz S, Ho B, Andreasen N.  Clinical features characterizing young-onset and intermediate-onset schizophrenia.  The Journal of Neuropsychiatry and Clinical Neurosciences.  2000. 12(4):502-5.
[PubMed]

Schultz S.  Dementia in the twenty-first century.  The American Journal of Psychiatry.  2000. 157(5):666-8.
[PubMed]

Whelan F, Walker M, Schultz S.  Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury.  Annals of Clinical Psychiatry.  2000. 12(3):131-5.
[PubMed]

Schultz S, Ellingrod V, Moser D, Arndt S.  Effects of psychiatric symptoms on functional skills among long-term care patients.  NCDUE annual meeting.  2000. 

Schultz S, Schilling M.  Info-connect: dementia, delirium and depression in the nursing home.  Educational module produced by the Geriatric Education Center.  2000. 

Turvey C, Schultz S, Arndt S, Wallace R, Herzog R.  Memory complaint in a community sample aged 70 and older.  Journal of the American Geriatrics Society.  2000. 48(11):1435-41.
[PubMed]

White T, Schultz S.  Naltrexone treatment for a 3-year-old boy with self-injurious behavior.  The American Journal of Psychiatry.  2000. 157(10):1574-82.
[PubMed]

Robinson R, Schultz S, Castillo C, Kopel T, Kosier J, Newman R, Curdue K, Petracca G, Starkstein S.  Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.  The American Journal of Psychiatry.  2000. 157(3):351-9.
[PubMed]

Schultz S.  Psychotic Disorders.  American Geriatric Society.  2000. 

Schultz S, Nopoulos P, Andreasen N.  The neuroanatomy of schizophrenia.  Williams and Wilkens; Baltimore.  2000. 

Atbasoglu C, Schultz S, Andreasen N.  The relationship between neuroleptic-induced akathisia and depressive symptoms.  APA Annual Meeting.  2000. 

Schultz S, O'Leary D, Boles Ponto L, Watkins G, Hichwa R, Andreasen N.  Age-related changes in regional cerebral blood flow among young to mid-life adults.  Neuroreport.  1999. 10(12):2493-6.
[PubMed]

Schultz S.  Assessment of psychosis in the elderly.  Vintage Iowa Gerontology Society.  1999. 

Ellingrod V, Schultz S, Arndt S.  Association between cytochrome P4502D6 (CYP2D6) genotype, neuroleptic exposure, and abnormal involuntary movements.  International Congress for Schizophrenia Research.  1999. 

Woodman C, Schultz S.  Faculty assessment of residents and the psychiatry resident-in-training examinations.  Academic Psychiatry.  1999. 23:137-141.

Schultz S, Arndt S, Ho B, Oliver S, Andreasen N.  Impaired glucose tolerance and abnormal movements in patients with schizophrenia.  The American Journal of Psychiatry.  1999. 156(4):640-2.
[PubMed]

Andreasen N, Schultz S.  Integrating functional and structural imaging.  Oxford University Press, Oxford.  1999. 

Crespo-Facorro B, Piven M, Schultz S.  Psychosis in late life: How does it fit into current diagnostic criteria?.  The American Journal of Psychiatry.  1999. 156(4):624-9.
[PubMed]

Magnotta V, Andreasen N, Schultz S, Harris G, Cizadlo T, Heckel D, Nopoulos P, Flaum M.  Quantitative in vivo measurement of gyrification in the human brain: changes associated with aging.  Cerebral Cortex ; New York, N.Y.  1999. 9(2):151-60.
[PubMed]

Schultz S, Andreasen N.  Schizophrenia.  Lancet.  1999. 353(9162):1425-30.
[PubMed]

Christensen A, Dornink R, Ehlers S, Schultz S.  Social environment and longevity in schizophrenia.  Psychosomatic Medicine.  1999. 61(2):141-5.
[PubMed]

Schultz S, O'Leary D, Andreasen N.  A positron emission tomography study of age- related changes in regional cerebral blood flow.  Society for Neuroscience 28th Annual Meeting.  1998. 

Schultz S, Dornink R.  A retrospective analysis of the hypoglycemic treatment of schizophrenia.  The American Journal of Geriatric Psychiatry.  1998. 6(3):43.

Schultz S, Miller D.  Effects of aging on psychotropic efficacy and toxicity.  Marcell Decker, Inc; New York.  1998. 

Schultz S.  Psychotic Disorders.  American Geriatric Society.  1998. 

Nopoulos P, Schultz S, Andreasen N.  Brain and Behavior.  Little, Brown and Co; Boston.  1997. 

Ziebell S, Schultz S, Andreasen N.  Clinical variables associated with suicide in patients with schizophrenia.  Schizophrenia Research.  1997. 24(1):26.

Andreasen N, Flaum M, Schultz S, Duzyurek S, Miller D.  Diagnosis, methodology and subtypes of schizophrenia.  Neuropsychobiology.  1997. 35(2):61-3.
[PubMed]

Schultz S, Miller D, Arndt S, Andreasen N.  Effects of low versus high potency neuroleptic withdrawal on symptoms and dyskinetic movements.  Schizophrenia Research.  1997. 24(1):266.

Schultz S, Castillo C, Kosier J, Robinson R.  Generalized anxiety and depression. Assessment over 2 years after stroke.  The American Journal of Geriatric Psychiatry.  1997. 5(3):229-37.
[PubMed]

Schultz S, Van de Borne P, Anderson E.  Heart rate variability before and after electroconvulsive therapy in patients with major depressive disorder.  Proceedings of the American Association for Geriatric Psychiatry annual meeting.  1997. 

Schultz S, Van de Borne P, Anderson E.  Sympathetic activity and metabolic rate in patients with anorexia nervosa.  American Psychiatric Association Annual meeting.  1997. 

Schultz S, Miller D, Oliver S, Arndt S, Flaum M, Andreasen N.  The life course of schizophrenia: age and symptom dimensions.  Schizophrenia Research.  1997. 23(1):15-23.
[PubMed]

Robinson R, Schultz S, Paradiso S.  Treatment of poststroke depression.  Marcell Decker, Inc; New York.  1997. 

Miller D, Schultz S, Alexander B.  Rational pharmacological approaches in the management of treatment-resistant schizophrenia.  Psychiatric Clinics of North America.  1996. 3:89-118.

Schultz S, Oliver S, Arndt S, Miller D, Andreasen N.  Schizophrenia and aging: A comparison of symptoms among age groups.  The American Journal of Geriatric Psychiatry.  1996. 4(4):344.

Flaum M, Schultz S.  The core symptoms of schizophrenia.  Annals of Medicine.  1996. 28(6):525-31.
[PubMed]

Flaum M, Schultz S.  When does amphetamine-induced psychosis become schizophrenia?.  The American Journal of Psychiatry.  1996. 153(6):812-5.
[PubMed]

Castillo C, Schultz S, Robinson R.  Clinical correlates of early-onset and late-onset poststroke generalized anxiety.  The American Journal of Psychiatry.  1995. 152(8):1174-9.
[PubMed]

Gupta S, Andreasen N, Arndt S, Flaum M, Schultz S, Hubbard W, Smith M.  Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.  The American Journal of Psychiatry.  1995. 152(2):191-6.
[PubMed]

Schultz S, Travis K, Ziebell S, Miller D, Arndt S, Andreasen N.  Polydipsia in neuroleptic naïve and treated patients with schizophrenia.  International Congress on Schizophrenia Research, Warm Springs, Virginia.  1995. 

Schultz S, Miller D, Arndt S, Ziebell S, Gupta S, Andreasen N.  Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.  Biological Psychiatry.  1995. 38(11):713-9.
[PubMed]

Travella J, Forrester A, Schultz S, Robinson R.  Depression following myocardial infarction: a one year longitudinal study.  International Journal of Psychiatry in Medicine.  1994. 24(4):357-69.
[PubMed]

Andreasen N, Nopoulos P, Schultz S, Miller D, Gupta S, Swayze V, Flaum M.  Positive and negative symptoms of schizophrenia: past, present, and future.  Acta Psychiatrica Scandinavica.  1994. 384:51-9.
[PubMed]

Andreason N, Schultz S.  Assessing the symptoms of schizophrenia in Handbook of Mental Health Economics and Health Policy.  Proceedings from Symposium: The Economics of Schizophrenia.  1993 September. 

Ponto L, Schultz S, Menda Y, Denburg N.  [18F]Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Study of Brain Metabolism among Elderly Women Breast Cancer Survivors.  Journal of Neuropsychiatry and Clinical Neurosciences. 

Devanand D, Schultz S.  Issues in Selecting Atypical Antipsychotics in Dementia.  The American Journal of Psychiatry. 

Schultz S.  Narrator for Audio-Digest Webcasts.  American Journal of Psychiatry; 

Date Last Modified: 12/17/2014 - 09:22:57